Byline: Will Doss
-
Exploring Flow Transport in Egg Cells
Motor proteins “slingshot” microtubules within developing egg cells of fruit flies, creating a current that transports mRNA to a developing egg.
-
Potassium Channel Dysfunction in Genetic Epilepsy
Northwestern Medicine scientists discovered functional links between dozens of potassium channel gene variants and neonatal epilepsy.
-
Proactive Machine Learning Could Speed Healthcare Innovation
Shifting machine learning workflows to a proactive model could speed data collection and analysis, according to a viewpoint published in JAMA.
-
Good Outcomes in COVID-19 Lung Transplants
Patients with COVID-19-associated lung disease who received lung transplants had similar outcomes compared to patients without COVID-19, according to a study published in JAMA.
-
Intensive Crohn’s Treatment is Safe
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.
-
Optimizing Balance of Treatments in Prostate Cancer
Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.
-
Genetics of Eosinophilic Colitis Revealed
A genetic analysis indicates eosinophilic colitis is distinct from other eosinophilic gastrointestinal diseases and inflammatory bowel disease, according to a recent study.
-
New Treatment for Metastatic Hormone-Sensitive Prostate Cancer
The drug darolutamid, administered with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer.
-
Elucidating Parkinson’s Disease
Recent advances from Northwestern investigators have powered a new, deeper understanding of Parkinson’s disease that could pave the way to a disease-modifying treatment.
-
Locoregional Therapy Does Not Improve Breast Cancer Survival
Treating breast tumors alongside distant metastases did not improve outcomes in women with stage IV breast cancer, according to a new study.
